PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-25 (225)
 

Clipboard (0)
None
Journals
Year of Publication
more »
1.  Most cases of research misconduct go undetected, conference told 
BMJ : British Medical Journal  2008;336(7650):913.
doi:10.1136/bmj.39556.698646.DB
PMCID: PMC2335224
2.  US ready for healthcare reform, conference told 
BMJ : British Medical Journal  2008;336(7648):797.
doi:10.1136/bmj.39542.551574.DB
PMCID: PMC2292315  PMID: 18403538
3.  For sale: estate car 
BMJ : British Medical Journal  2008;336(7639):321.
doi:10.1136/bmj.39199.735104.BE
PMCID: PMC2234550
4.  Should we loosen the grip on drug companies? 
BMJ : British Medical Journal  2007;335(7617):454.
It costs $40bn a year to produce just a handful of new drugs. Richard Smith reviews a highly publicised new book that claims over-regulation is holding the drug industry back.
doi:10.1136/bmj.39300.656030.4E
PMCID: PMC1962855
5.  Should medical journals carry drug advertising? Yes 
BMJ : British Medical Journal  2007;335(7610):74.
No one can fail to notice the adverts in medical journals but are they really necessary? Richard Smith maintains they are essential to editorial independence, whereas Gareth Williams argues that they undermine a journal's integrity
doi:10.1136/bmj.39259.472998.AD
PMCID: PMC1914452  PMID: 17626959
6.  Social measures may control pandemic flu better than drugs and vaccines 
BMJ : British Medical Journal  2007;334(7608):1341.
doi:10.1136/bmj.39255.606713.DB
PMCID: PMC1906625  PMID: 17599996
7.  The Story of San Michele 
BMJ : British Medical Journal  2007;334(7596):751.
doi:10.1136/bmj.39167.673808.59
PMCID: PMC1847877
8.  Doubts over head injury studies  
BMJ : British Medical Journal  2007;334(7590):392-394.
Patients are receiving treatment that may be unsound as investigations by Ian Roberts and colleagues raise questions about whether influential trials of high dose mannitol ever took place
doi:10.1136/bmj.39118.480023.BE
PMCID: PMC1804156  PMID: 17322250
9.  ISTC programme is an expensive option 
BMJ : British Medical Journal  2007;334(7587):222.
doi:10.1136/bmj.39108.384572.1F
PMCID: PMC1790733  PMID: 17272536
10.  Open letter to the leader of academic medicine 
BMJ : British Medical Journal  2007;334(7586):191-193.
As their campaign comes to a close, ICRAM presents a challenge to academic medicine's invisible leaders
doi:10.1136/bmj.39043.676898.94
PMCID: PMC1782025  PMID: 17255613
11.  The House of God 
BMJ : British Medical Journal  2007;334(7584):99.
doi:10.1136/bmj.39084.673889.59
PMCID: PMC1767272
12.  Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial 
BMJ : British Medical Journal  2007;334(7603):1098.
Objective To test whether a drug review and symptom self management and lifestyle advice intervention by community pharmacists could reduce hospital admissions or mortality in heart failure patients.
Design Randomised controlled trial.
Setting Home based intervention in heart failure patients.
Participants 293 patients diagnosed with heart failure were included (149 intervention, 144 control) after an emergency admission.
Intervention Two home visits by one of 17 community pharmacists within two and eight weeks of discharge. Pharmacists reviewed drugs and gave symptom self management and lifestyle advice. Controls received usual care.
Main outcome measures The primary outcome was total hospital readmissions at six months. Secondary outcomes included mortality and quality of life (Minnesota living with heart failure questionnaire and EQ-5D).
Results Primary outcome data were available for 291 participants (99%). 136 (91%) intervention patients received one or two visits. 134 admissions occurred in the intervention group compared with 112 in the control group (rate ratio=1.15, 95% confidence interval 0.89 to 1.48; P=0.28, Poisson model). 30 intervention patients died compared with 24 controls (hazard ratio=1.18, 0.69 to 2.03; P=0.54). Although EQ-5D scores favoured the intervention group, Minnesota living with heart failure questionnaire scores favoured controls; neither difference was statistically significant.
Conclusion This community pharmacist intervention did not lead to reductions in hospital admissions in contrast to those found in trials of specialist nurse led interventions in heart failure. Given that heart failure accounts for 5% of hospital admissions, these results present a problem for policy makers who are faced with a shortage of specialist provision and have hoped that skilled community pharmacists could produce the same benefits.
Trial registration number ISRCTN59427925.
doi:10.1136/bmj.39164.568183.AE
PMCID: PMC1877883  PMID: 17452390
13.  Time to legalise assisted dying? 
BMJ : British Medical Journal  2005;331(7520):842-843.
PMCID: PMC1246127  PMID: 16210292
14.  Investigating the previous studies of a fraudulent author 
BMJ : British Medical Journal  2005;331(7511):288-291.
This year, the journal Nutrition retracted a study by R K Chandra, and questions have been raised about the integrity of the rest of his work. Who has the responsibility for investigating previous work and if necessary punishing the researcher and correcting the scientific record?
PMCID: PMC1181274  PMID: 16052023
15.  Perceptions of open access publishing: interviews with journal authors 
BMJ : British Medical Journal  2005;330(7494):756.
Objective To explore authors' attitudes towards open access publishing and author charges, their perceptions of journals that charge authors, and whether they would be willing to submit to these journals.
Design Semistructured telephone interviews.
Participants 28 randomly selected international authors who submitted to the BMJ in 2003.
Results Authors were more aware of the concepts of open access publishing and author pays models than previously reported. Almost all authors supported the concept of open access, but few had submitted to an open access journal, other than the BMJ. Reasons for not submitting included lack of awareness of which journals publish with open access, and journal quality taking a higher priority in decision making than the availability of open access. Authors disliked the idea of author charges without institutional support and were concerned about implications for authors from developing countries and those without research funding. However, many said they would probably continue to submit to journals they perceived as being of high quality even if they charged authors.
Conclusions Authors consider perceived journal quality as more important than open access when deciding where to submit papers. New journals with open access may need to do more to reassure authors of the quality of their journals.
doi:10.1136/bmj.38359.695220.82
PMCID: PMC555876  PMID: 15677363
17.  What can the UK and US health systems learn from each other? 
BMJ : British Medical Journal  2005;330(7490):530-533.
The NHS and US insurance based health systems seem worlds apart. Despite the differences, each has much to learn from examples of good practice in the other
PMCID: PMC552818  PMID: 15746136
18.  Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial 
BMJ : British Medical Journal  2005;330(7486):293.
Objective To determine whether home based medication review by pharmacists affects hospital readmission rates among older people.
Design Randomised controlled trial.
Setting Home based medication review after discharge from acute or community hospitals in Norfolk and Suffolk.
Participants 872 patients aged over 80 recruited during an emergency admission (any cause) if returning to own home or warden controlled accommodation and taking two or more drugs daily on discharge.
Intervention Two home visits by a pharmacist within two weeks and eight weeks of discharge to educate patients and carers about their drugs, remove out of date drugs, inform general practitioners of drug reactions or interactions, and inform the local pharmacist if a compliance aid is needed. Control arm received usual care.
Main outcome measure Total emergency readmissions to hospital at six months. Secondary outcomes included death and quality of life measured with the EQ-5D.
Results By six months 178 readmissions had occurred in the control group and 234 in the intervention group (rate ratio = 1.30, 95% confidence interval 1.07 to 1.58; P = 0.009, Poisson model). 49 deaths occurred in the intervention group compared with 63 in the control group (hazard ratio = 0.75, 0.52 to 1.10; P = 0.14). EQ-5D scores decreased (worsened) by a mean of 0.14 in the control group and 0.13 in the intervention group (difference = 0.01, -0.05 to 0.06; P = 0.84, t test).
Conclusions The intervention was associated with a significantly higher rate of hospital admissions and did not significantly improve quality of life or reduce deaths. Further research is needed to explain this counterintuitive finding and to identify more effective methods of medication review.
doi:10.1136/bmj.38338.674583.AE
PMCID: PMC548182  PMID: 15665005
20.  The GMC: expediency before principle 
BMJ : British Medical Journal  2005;330(7481):1-2.
PMCID: PMC539824  PMID: 15626781
21.  A fool such as I 
BMJ : British Medical Journal  2004;329(7480):1494.
PMCID: PMC536002
23.  My last choice 
BMJ : British Medical Journal  2004;329(7460):0.
PMCID: PMC498008

Results 1-25 (225)